The objective of this study is to analyze the enhancement patterns of hepatic tumors in different vascular phases using dynamic contrast-enhanced ultrasonography (CEUS).We performed dynamic CEUS in consecutive patients, and included a total of 61 patients (M = 41 , F = 20) with 69 proven focal hepatic tumors in this study. The hepatic tumors included hepatocellular carcinoma (HCC, n = 49), metastases (n = 6), cholangiocarcinoma (n = 3), hemangioma (n = 9) and focal nodular hyperplasia (FNH, n = 2), Most of the patients with HCC had underlying diseases such as hepatitis B (n = 26) 01' C (n = 12). After intravenous administration of micro-bubble contrast agent, video recordings were made. Three phases: initial, vascular and delayed phases were recorded and analyzed, ANOVA was used for statistical analysis, P value less than 0.05 is considered statistically significant. Two radiologists who were blind to the final diagnosis of hepatic tumors reviewed the video respectively. Interobsever difference was analyzed by kappa test.In the vascular phase, the enhancement is mainly marginal for HCCs (36.7%), peripheral for hemangioma (88.9%), no-enhancement (50.0%) or marginal enhancement (50.0%) for metastasis, while all the FNH showed internal enhancement and all the cholangiocarcinomas show no enhancement. In the delayed phase, the enhancement pattern is mainly inhomogeneous (59.2%) for HCCs, isoechoic (66.7%) for hemangioma, and hypoechoic (66.7%) for both metastases and cholangiocarcinoma; while FNHs were either hypoechoic (50%) or hyperechoic (50%), The interobserver difference is good (k = 0.62, 0.75).CEUS is useful in characterizing various hepatic tumors and may sometimes help in suggesting accurate diagnoses.
為了持續優化網站功能與使用者體驗,本網站將Cookies分析技術用於網站營運、分析和個人化服務之目的。
若您繼續瀏覽本網站,即表示您同意本網站使用Cookies。